Compare VSH & GRFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VSH | GRFS |
|---|---|---|
| Founded | 1962 | 1940 |
| Country | United States | Spain |
| Employees | N/A | N/A |
| Industry | Electrical Products | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.0B | 5.2B |
| IPO Year | 1994 | 2008 |
| Metric | VSH | GRFS |
|---|---|---|
| Price | $31.58 | $7.80 |
| Analyst Decision | Sell | Hold |
| Analyst Count | 2 | 2 |
| Target Price | ★ $18.00 | $10.15 |
| AVG Volume (30 Days) | ★ 2.8M | 344.9K |
| Earning Date | 05-13-2026 | 07-28-2022 |
| Dividend Yield | 1.44% | ★ 1.80% |
| EPS Growth | ★ 69.57 | N/A |
| EPS | ★ 0.25 | N/A |
| Revenue | ★ $3,069,048,000.00 | N/A |
| Revenue This Year | $12.58 | $4.49 |
| Revenue Next Year | $6.69 | $6.42 |
| P/E Ratio | $122.92 | ★ $18.67 |
| Revenue Growth | ★ 4.48 | N/A |
| 52 Week Low | $11.77 | $6.96 |
| 52 Week High | $69.47 | $10.23 |
| Indicator | VSH | GRFS |
|---|---|---|
| Relative Strength Index (RSI) | 40.99 | 50.88 |
| Support Level | $29.78 | $7.66 |
| Resistance Level | $36.58 | $8.36 |
| Average True Range (ATR) | 1.36 | 0.18 |
| MACD | 0.25 | -0.03 |
| Stochastic Oscillator | 19.75 | 28.64 |
Vishay Intertechnology Inc provides a broad product portfolio of discrete semiconductors and passive electronic components to original equipment manufacturers and distributors. These products are found in industrial, computing, automotive, consumer, telecommunications, power supplies, military, aerospace, and medical markets and serve customer all over the world. Its product segments consist of two general classes: semiconductors and passive components. The company's operating segment includes metal oxide semiconductor field-effect transistors, diodes, optoelectronic components, resistors, inductors, and capacitors. Revenue mainly comes from resistors, which are basic components used in all forms of electronic circuitry to adjust and regulate levels of voltage and current.
Grifols SA is a healthcare company engaged in activities related to plasma-derived products and diagnostic solutions. The group has four reportable segments: Biopharma, Diagnostic, Bio Supplies, and Others. The Biopharma segment focuses on products derived from human plasma for therapeutic use, while the Diagnostic segment includes the marketing of diagnostic testing equipment and reagents. The Bio Supplies segment covers biological products for non-therapeutic use and plasma sales to third parties, and the Others segment includes manufacturing services, research activities, and complementary pharmaceutical products.